Centene Corp
NYSE:CNC
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
57.46
80.41
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Centene Corp
Centene Corp
Accounts Receivables
Centene Corp
Accounts Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Centene Corp
NYSE:CNC
|
Accounts Receivables
$18.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
UnitedHealth Group Inc
NYSE:UNH
|
Accounts Receivables
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Molina Healthcare Inc
NYSE:MOH
|
Accounts Receivables
$3.3B
|
CAGR 3-Years
19%
|
CAGR 5-Years
21%
|
CAGR 10-Years
23%
|
|
|
Humana Inc
NYSE:HUM
|
Accounts Receivables
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Healthequity Inc
NASDAQ:HQY
|
Accounts Receivables
$108.5m
|
CAGR 3-Years
13%
|
CAGR 5-Years
32%
|
CAGR 10-Years
33%
|
|
|
Elevance Health Inc
NYSE:ELV
|
Accounts Receivables
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Centene Corp
Glance View
Centene Corporation is a prominent player in the healthcare sector, known for its innovative approach to delivering affordable and accessible health insurance solutions. Founded in 1984, this Fortune 500 company has grown significantly, primarily focusing on government-sponsored healthcare programs, including Medicaid and Medicare. Centene's diverse health plans serve a wide demographic, including low-income families, the aging population, and those with complex healthcare needs. Through strategic acquisitions, robust technology investments, and a commitment to community-based care, Centene has positioned itself as a key provider in the rapidly evolving healthcare landscape. What sets Centene apart is its relentless focus on integrated healthcare solutions and patient-centric services. By leveraging data analytics and personalized care strategies, the company aims to improve health outcomes while managing costs effectively. In recent years, Centene has expanded its footprint by acquiring organizations that enhance its capabilities and market presence. This growth strategy not only strengthens its service offerings but also fortifies its competitive edge. For investors, Centene represents a compelling opportunity, combining steady revenue growth, a commitment to innovation, and a mission-driven approach that aims to bridge the gap in healthcare access for underserved populations.
See Also
What is Centene Corp's Accounts Receivables?
Accounts Receivables
18.3B
USD
Based on the financial report for Sep 30, 2024, Centene Corp's Accounts Receivables amounts to 18.3B USD.
What is Centene Corp's Accounts Receivables growth rate?
Accounts Receivables CAGR 1Y
18%
Over the last year, the Accounts Receivables growth was 18%.
You don't have any saved screeners yet
